In 2024 US venture capital stopped behaving like one market. Rate cuts arrived and exits did not reopen, because the constraint had moved somewhere the rate cuts could not reach.
2024 should, on the standard framework, have been a recovery year for US venture capital. Rates fell. Public markets performed well. The 2021 vintage's problems were largely acknowledged and marked. The conditions that caused the contraction had reversed.
The recovery was partial and uneven, and understanding why is the substance of the year.
The constraint had moved. In 2022 the problem was the cost of capital — higher rates made long-duration assets less valuable, and the repricing followed mechanically. By 2024 the problem was the availability of capital at the LP level, which is a different variable and one that rate cuts do not directly address.
The chain described in the 2023 report had not been repaired. Distributions were still well below the level needed to sustain commitment pacing, because exits had not reopened at scale. Rate cuts lower the cost of capital, but they do not make an institution's private portfolio return cash. A constraint that operates through liquidity rather than price is not relieved by making price cheaper.
The second defining feature was the deepening separation between two populations of companies. Businesses with a credible AI position experienced a market resembling 2021 — abundant capital, rapid processes, competitive rounds. Businesses without one experienced a market resembling 2023. Both were true simultaneously and within the same asset class.
Underneath both, a slower change was occurring that received almost no attention: the pipeline of new venture firms was thinning. That is a change to the industry's composition rather than its conditions, and it compounds over a much longer horizon.
This is the most important analytical point of 2024 and it generalises well beyond venture capital.
The standard model says lower rates support asset prices and reopen capital markets. That model is correct when the constraint is the cost of capital.
By 2024 the venture constraint was elsewhere. The loop runs: exits → distributions to LPs → new commitments → fund deployment. It had broken at the first link, and each subsequent link had constricted in turn.
Rate cuts affect this loop only indirectly, and each transmission step is slow and lossy:
There is a further friction that is rarely stated. A company whose last private round priced it above what public markets will pay has an incentive to wait, because listing crystallises a loss for existing investors that remains theoretical while private. That incentive persists until either the company grows into the valuation or its investors accept the adjustment. Neither happens quickly, and both are decisions made by people whose compensation is affected by the outcome.
Rate cuts change what capital costs. The 2024 problem was that capital had not come back — a distinction that determines which policy levers work and which do not.
The general principle is worth stating on its own: when a system has multiple potential constraints, relieving one that is not binding produces no effect. Diagnosing which constraint is actually binding is the analytical work, and it is frequently skipped in favour of applying the familiar framework.
The separation that became sharp in 2025 was clearly visible in 2024, and its mechanics are worth setting out at the transaction level.
Population one comprised companies with a credible artificial intelligence position — at the model layer, in infrastructure, or in applications with demonstrable adoption. For these companies:
Population two comprised everything else. For these companies:
The same investors participated in both markets, applying different standards depending on which population a company fell into. That is not inconsistency — it reflects genuinely different competitive conditions in the two segments.
The practical difficulty this created was classification. Whether a company counted as population one was frequently ambiguous, and the answer materially affected its valuation and its access to capital. This produced predictable behaviour: companies repositioned their narratives toward AI, sometimes reflecting genuine product changes and sometimes reflecting the incentive to be classified favourably.
For investors, this made diligence harder in a specific way. The question shifted from "is this a good business" to "is this AI position real" — and the second question requires technical assessment that not every investment team was equipped to perform.
A structural shift occurred in 2024 that changed what venture capital could fund, and it received less attention than the valuations did.
Artificial intelligence had previously been a software category. Software has favourable capital characteristics: development costs are largely people, marginal costs approach zero, and a company can reach substantial revenue on modest capital.
Frontier model development is not that. It requires:
This changes the economics of funding such a company by roughly an order of magnitude. A venture fund that could seed twenty software companies could seed a fraction of one frontier model developer.
The consequences reshaped the market's structure:
The 2024 slot-A report describes this reclassification at the macro level. At the venture level, its significance is that a category which venture capital had considered its own moved partly outside the range that venture capital can fund.
The least visible development of 2024 concerns the composition of the industry rather than its conditions.
New venture firms — first and second-time funds — are the mechanism by which the industry renews itself. They introduce new strategies, new geographic focus, new networks, and they are frequently where the highest-returning funds of a vintage originate, because a small fund concentrated in an under-covered area can produce returns a large diversified one cannot.
Raising a first fund in 2024 was extremely difficult, and the reasons were structural rather than performance-related:
The effect compounds slowly and is hard to reverse. A manager who cannot raise a first fund in 2024 does not raise a second in 2027 or a third in 2030. The cost appears a decade later, as a gap in the population of established managers — precisely analogous to the company-level cohort gap described in the 2025 and 2026 reports, operating one level up the capital chain.
A practical change in fund management became dominant in 2024: the reserve allocation decision.
Venture funds hold back a portion of capital for follow-on investments in existing portfolio companies. In favourable conditions this is straightforward — support the winners, let the others resolve.
By 2024 the calculation had changed:
The result was that a much higher share of deployment went to existing positions rather than new ones. That is rational at the portfolio level but has a market-level consequence: capital allocated to reserves is capital not available to new companies. Some of the reduction in new company formation in 2024 reflects this reallocation rather than any judgement about the opportunities.
The two-population structure created a diligence difficulty that was new in kind rather than degree, and it is worth setting out because it changed what venture diligence has to be able to do.
The shift in the question. In a normal market the diligence question is whether a business is good — the market, the team, the product, the economics. In 2024 an additional question came first and frequently dominated: is this company's AI position real?
Why that question is harder:
The practical questions that separated the two:
When a category determines price, classification becomes the diligence. That is an uncomfortable position, because it means the most consequential judgement in the process is the one least amenable to the tools most investors have.
Diagnose which constraint is binding before applying a remedy. Rate cuts address the cost of capital and do nothing for its availability. In 2024 the constraint was availability — distributions had not recovered, so commitments could not be made. A familiar remedy producing no effect is diagnostic information, and the correct conclusion is that the constraint has moved rather than that more of the remedy is needed.
Measure distributions as a percentage of NAV. It measures capital returned. Listing counts measure activity. Only the first relieves the constraint that determines commitment pacing, and Bain publishes it free.
Separate the capital intensity question from the thematic one. A category whose capital requirement rises by an order of magnitude may move outside the range a venture fund can fund, regardless of how attractive the theme is. A fund sized for software economics cannot participate at infrastructure scale, and repositioning toward the application layer was the rational response rather than a retreat.
Watch first-time fund formation. NVCA/PitchBook reports it separately and free. A manager who cannot raise a first fund in 2024 does not raise a third in 2030, and the cost appears a decade later as a gap in the population of established managers — the same cohort-gap mechanism operating one level up the capital chain.
Ask about reserve policy. A much higher share of deployment went to existing positions in 2024 than to new ones. That is rational at the portfolio level and it means capital allocated to reserves is capital not available to new companies. Some of the reduction in new company formation reflects this reallocation rather than any judgement about opportunities.
A structural retrospective on US venture capital in 2024, focused on why the expected recovery did not arrive and what changed in the industry's structure.
Where figures appear they carry a numbered source. Mechanisms — constraint migration, the distribution-to-commitment loop, capital intensity and fundability, manager pipeline compounding, reserve displacement — are analysis with reasoning shown.
This report follows from the 2023 slot-B report and reads directly into 2025 slot A, which describes the two-population structure at its sharpest.
US Venture Capital Report 2023 — The Reset precedes this report in the North America sequence.
US Venture Capital Report 2025 — Concentration follows this report in the North America sequence.
Global Investment Outlook 2024 — The Capex Turn covers the same year at global multi-asset level.
Accredited investors receive our market reports, private event invitations and curated deal flow.
.png)




